Literature DB >> 3148070

Serotonin and noradrenaline concentrations and serotonin uptake in platelets from hyperphenylalaninaemic patients.

M Giovannini1, R Valsasina, R Longhi, A M Cesura, M D Galva, E Riva, G P Bondiolotti, G B Picotti.   

Abstract

In three untreated patients with phenylketonuria (PKU), three PKU and six hyperphenylalaninaemic (HPA) patients in good metabolic control, the kinetic constants of platelet in vitro uptake of [14C]serotonin (5HT) did not significantly differ from those in 12 control subjects matched for age. The platelet concentrations of endogenous 5HT and noradrenaline (NA), taken as long-term indices of the amount of these amines circulating in plasma, were lower than normal in PKU and HPA patients, whether or not they were kept on a diet. However, a reduction in plasma NA concentrations at the moment of blood collection was seen only in untreated PKU patients. These data indicate that there may be a chronic inhibition of 5HT and possibly of NA synthesis even in PKU or HPA subjects in good metabolic control, with normal psychomotor development and only slightly raised plasma phenylalanine levels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148070     DOI: 10.1007/bf01800371

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

1.  Decreased 5-hydroxytryptophan decarboxylase activity in phenylketonuria.

Authors:  C M PARE; M SANDLER; R S STACEY
Journal:  Lancet       Date:  1958-11-22       Impact factor: 79.321

2.  Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.

Authors:  R Malmgren
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain.

Authors:  C M McKean
Journal:  Brain Res       Date:  1972-12-12       Impact factor: 3.252

4.  The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain.

Authors:  C M McKean; D E Boggs; N A Peterson
Journal:  J Neurochem       Date:  1968-03       Impact factor: 5.372

5.  Free (unconjugated) catecholamine concentrations in platelets: biological significance and clinical implications.

Authors:  G B Picotti; G P Bondiolotti; A M Cesura; C Ravazzani; M D Galva; P Mantegazza
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

6.  Serotonin and dopamine synthesis in phenylketonuria.

Authors:  H C Curtius; A Niederwieser; M Viscontini; W Leimbacher; H Wegmann; B Blehova; F Rey; J Schaub; H Schmidt
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

7.  Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.

Authors:  M Da Prada; G B Picotti
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

8.  Plasma adrenaline, noradrenaline and dopamine in man and different animal species.

Authors:  H U Bühler; M da Prada; W Haefely; G B Picotti
Journal:  J Physiol       Date:  1978-03       Impact factor: 5.182

9.  Inhibition by L-phenylalanine of tryptophan transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria.

Authors:  E Herrero; M C Aragon; C Gimenez; F Valdivieso
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

10.  Effects of mazindol and d-fenfluramine of 5-hydroxytryptamine uptake, storage and metabolism in blood platelets.

Authors:  G B Picotti; M O Carruba; F Zambotti; P Mantegazza
Journal:  Eur J Pharmacol       Date:  1977-04-07       Impact factor: 4.432

View more
  5 in total

1.  Platelet serotonin concentrations in PKU patients under dietary control and tetrahydrobiopterin treatment.

Authors:  A Ormazabal; M A Vilaseca; B Pérez-Dueñas; N Lambruschini; L Gómez; J Campistol; R Artuch
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Fatty acid metabolism in phenylketonuria.

Authors:  M Giovannini; C Agostoni; G Biasucci; A Rottoli; D Luotti; S Trojan; E Riva
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

3.  Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria.

Authors:  A G Antoshechkin; T V Chentsova; D B Naritsin; G P Railian
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

4.  Serum serotonin levels and bone in rheumatoid arthritis patients.

Authors:  Miguel Bernardes; Tiago Vieira; Raquel Lucas; Jorge Pereira; Lúcia Costa; Francisco Simões-Ventura; Maria João Martins
Journal:  Rheumatol Int       Date:  2017-10-09       Impact factor: 2.631

Review 5.  Engineering Organoids for in vitro Modeling of Phenylketonuria.

Authors:  Alice C Borges; Kerensa Broersen; Paula Leandro; Tiago G Fernandes
Journal:  Front Mol Neurosci       Date:  2022-01-10       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.